BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. SNCA, Fatty acid metabolic process, Inflammatory disorder, Breast, Pharmacogenetics)
Bookmark Forward

QuickView for BCL-xL (gene)


Body Atlas

Most Correlated Tissues

  1. Bone marrow
  2. Thymus gland
  3. Kidney cortex
  4. Ileum mucosa
  5. Kidney medulla
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Bacterial sepsis of newborn
  2. Herpesvirus infection
  3. Bleeding
  4. Sepsis due to coagulase negative Staphylococcus
  5. Abscess
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Caerulein
  2. ozagrel
  3. Pindolol
  4. Milrinone
  5. Dothiepin
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MIR206
  2. REL
  3. HBB
  4. CASP10
  5. Mcs5
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Anti-apoptotic protein BCL-XL as a therapeutic vulnerability in gastric cancer.
  2. Ser14 phosphorylation of Bcl-xL mediates compensatory cardiac hypertrophy in male mice.
  3. Bcl-xL: A Focus on Melanoma Pathobiology.
  4. Roles and Regulation of BCL-xL in Hematological Malignancies.
  5. Impact of Deamidation on the Structure and Function of Antiapoptotic Bcl-xL.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal …
  2. Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP)
  3. Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent …
  4. Bcl-XL_42-CAF09b Vaccination for Patients With Prostate Cancer With Lymph Node Metastases
  5. Studying Cells Collected Through Ductal Lavage in Women Undergoing Surgery for Ductal Carcinoma In S…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.